Histogenex

Development of predictive biomarkers for cancer treatment through pathology and molecular biology

placeKluisbergen, Flanders, Belgium calendar_todayFounded 2001 groups150 employees language histogenex.com

Registered entities

Investor mix

2 investors on record.

Investor typeCountShare
Private equity150%
Other / undisclosed150%
Coming soon